相关实验视频
Updated: Jun 11, 2025

09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
15.4K
布雷克西普拉在治疗耐药性强迫症中增加:在意大利样本中的安全性和有效性
Vassilis Martiadis1, Enrico Pessina, Azzurra Martini
1Department of Mental Health, Asl Napoli 1 Centro, Via Fermariello 28, 80125, Naples, Italy, vassilis.martiadis@gmail.com.
Psychiatria Danubina
|October 8, 2024
概括
布雷克西普拉增强剂可能对耐治疗强迫症 (OCD) 患者有效. 在这项研究中,50%的患者通过将布雷克斯皮普拉添加到血清素再吸收抑制剂 (SRIs) 中显示出改善,副作用通常是轻微的.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 强迫症 (OCD) 影响2.5%的人口.
- 血清素再吸收抑制剂 (SRIs) 是强迫症的第一线治疗方法,但50%的患者没有反应.
- 非典型的抗精神病药物用于治疗抗性强迫症.
研究的目的:
- 研究布雷克斯皮普拉作为SRI耐药性强迫症患者的增强策略的安全性和有效性.
- 评估布雷克斯皮普拉对YBOCS评分和不良体验的影响.
主要方法:
- 对34名治疗耐药性强迫症患者的回顾性研究.
- 在12周的增强试验中,布雷克斯皮普拉与SRI一起使用.
- 治疗耐药性定义为SRI单疗时YBOCS得分<25%的改善.
主要成果:
- 50%的患者 (17/34) 达到应答标准 (≥25%的YBOCS改善).
- 没有报告任何重大安全问题.
- 55.9%的患者经历了轻微的,不干扰的不良体验.
结论:
- 布雷克西普拉似乎是一种安全且潜在的有效增强策略,用于SRI耐性强迫症.
- 需要对更大种群进行进一步的研究,以确认长期的安全性和有效性.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
197
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
197
Obsessive-Compulsive Disorder
56
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
56
Electroconvulsive Therapy
26
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
26

